Relief Therapeutics Holding AG
RLF.SW
Price:
$2.25
Market Cap:
$28.02M
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lu...[Read more]
Industry
Biotechnology
IPO Date
2009-08-26
Stock Exchange
SIX
Ticker
RLF.SW
The ROE as of September 2024 (TTM) for Relief Therapeutics Holding AG (RLF.SW) is -91.12%
According to Relief Therapeutics Holding AG’s latest financial reports and current stock price. The company's current ROE is -91.12%. This represents a change of 120.04% compared to the average of -41.41% of the last 4 quarters.
Relief Therapeutics Holding AG (RLF.SW) Historical ROE (quarterly & annually)
How has RLF.SW ROE performed in the past?
The mean historical ROE of Relief Therapeutics Holding AG over the last ten years is -49.59%. The current -91.12% ROE has changed 83.76% with respect to the historical average. Over the past ten years (40 quarters), RLF.SW's ROE was at its highest in in the December 2012 quarter at 113.72%. The ROE was at its lowest in in the December 2011 quarter at -349.38%.
Average
-49.59%
Median
-40.76%
Minimum
-187.99%
Maximum
-2.05%
Relief Therapeutics Holding AG (RLF.SW) ROE by Quarter and Year
Discovering the peaks and valleys of Relief Therapeutics Holding AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.45%
Maximum Annual ROE = -2.05%
Minimum Annual Increase = -85.14%
Minimum Annual ROE = -187.99%
| Year | ROE | Change |
|---|---|---|
| 2023 | -187.99% | 438.22% |
| 2022 | -34.93% | 82.69% |
| 2021 | -19.12% | 63.74% |
| 2020 | -11.68% | -77.62% |
| 2019 | -52.18% | 2.45% |
| 2018 | -2.05% | -85.14% |
| 2017 | -13.78% | -81.79% |
| 2016 | -75.71% | 46.02% |
| 2015 | -51.85% | 11.29% |
| 2014 | -46.59% | -22.86% |
Relief Therapeutics Holding AG (RLF.SW) Average ROE
How has RLF.SW ROE performed in the past?
The current ROE of Relief Therapeutics Holding AG (RLF.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-80.68%
5-year avg
-61.18%
10-year avg
-49.59%
Relief Therapeutics Holding AG (RLF.SW) ROE vs. Peers
How is RLF.SW’s ROE compared to its peers?
Relief Therapeutics Holding AG’s ROE is greater than Relief Therapeutics Holding AG (-199.25%), greater than Meyer Burger Technology AG (-145.34%), less than NRx Pharmaceuticals, Inc. (193.11%), less than Dufry AG (5.40%), greater than Evolva Holding SA (-588.99%),
| Company | ROE | Market cap |
|---|---|---|
| -199.25% | $32.50M | |
| -145.34% | $60.56M | |
| 193.11% | $17.41M | |
| 5.40% | $4.51B | |
| -588.99% | $6.56M |
Build a custom stock screener for Relief Therapeutics Holding AG (RLF.SW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relief Therapeutics Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Relief Therapeutics Holding AG (RLF.SW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Relief Therapeutics Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Relief Therapeutics Holding AG's ROE?
How is the ROE calculated for Relief Therapeutics Holding AG (RLF.SW)?
What is the highest ROE for Relief Therapeutics Holding AG (RLF.SW)?
What is the 3-year average ROE for Relief Therapeutics Holding AG (RLF.SW)?
What is the 5-year average ROE for Relief Therapeutics Holding AG (RLF.SW)?
How does the current ROE for Relief Therapeutics Holding AG (RLF.SW) compare to its historical average?